News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
FDA Chief: COVID Vaccine in Pregnancy Should Be Personal Choice
Dr. Marty Makary, head of the U.S. Food and Drug Administration (FDA), said Wednesday that the decision should be made between a pregnant woman and her doctor. “The data on the COVID vaccine booster in pregnant women is a mixed set of data,” Makary said in an interview. “Now, I think the decision should be between a doctor and a pregnant woman.”
In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...
Moderna’s newest lower-dose COVID-19 vaccine is approved for all adults 65 and older, and for people aged 12 to 64 who are at ...
MedPage Today on MSN1d
CDC Expert Resigns From COVID Vax Role; FDA to Probe Abortion Drug; Measles UpdateA top CDC official said she was resigning from her role overseeing updates to the agency's COVID-19 vaccine recommendations ...
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.
Despite Health Secretary Robert F Kennedy Jr’s announcement ending covid-19 vaccine recommendations for healthy children and pregnant women, the Centers for Disease Control and Prevention (CDC) has ...
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...
The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback